F
Federico Aucejo
Researcher at Cleveland Clinic
Publications - 189
Citations - 3507
Federico Aucejo is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Liver transplantation & Medicine. The author has an hindex of 28, co-authored 146 publications receiving 2535 citations. Previous affiliations of Federico Aucejo include Cleveland Clinic Lerner College of Medicine.
Papers
More filters
Journal ArticleDOI
Oncologic results of laparoscopic liver resection for malignant liver tumors.
Muhammet Akyüz,Pinar Yazici,Hakan Yigitbas,Cem Dural,Alexis K. Okoh,Shamil Aliyev,Federico Aucejo,Cristiano Quintini,John J. Fung,Eren Berber +9 more
TL;DR: The aim of this study is to analyze the oncologic outcomes of LLR for malignant liver tumors (MLT) in patients undergoing laparoscopic liver resection for cancerous liver tumors.
Journal ArticleDOI
Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization
Joseph L. McDevitt,Ali Alian,Baljendra Kapoor,Stacy Bennett,Amanjit Gill,Abraham Levitin,Mark J. Sands,K. V. Narayanan Menon,Federico Aucejo,Bassam Estfan,Anil K. Pillai,Sanjeeva P. Kalva,Gordon McLennan +12 more
TL;DR: 90Y radioembolization and DEE chemoembolizations provided similar overall survival in the treatment of infiltrative HCC without main portal vein invasion, and abdominal pain and fever were more frequent after DEe chemoEmbolization.
Journal ArticleDOI
Adjuvant treatment of hepatocellular carcinoma after orthotopic liver transplantation: do we really need this?
TL;DR: The current data on efficacy and rationale of adjuvant treatment for HCC after OLT including novel biomarkers are reviewed.
Journal ArticleDOI
Initial experience with a new articulating energy device for laparoscopic liver resection
TL;DR: This initial study shows that the new device is safe and efficient for LLR, and its main advantage is shortening of hepatic parenchymal transection time, which has implications for increasing efficiency and cost saving in LLR.
Journal ArticleDOI
Expanding the donor pool: Safe transplantation of a cadaveric liver allograft with a 10cm cavernous hemangioma - A case report
Federico Aucejo,Werner Andrade Ortiz,Dympna Kelly,Charles Winans,David P. Vogt,Bijan Eghtesad,John J. Fung,Charles Miller +7 more
TL;DR: A standard ortho-topic liver transplant procedure into a 53-year-old male with end-stageliver disease secondary to hepatitis C and hepatocellu-lar carcinoma outside of the Milan criteria.